Page 98 - ARNM-2-4

Advances in Radiotherapy
& Nuclear Medicine Malignant peripheral nerve sheath tumor: A case report

References nerve sheath tumors. Oncologist. 2014;19(2):193-201.

1. Cai Z, Tang X, Liang H, Yang R, Yan T, Guo W. Prognosis doi: 10.1634/theoncologist.2013-0328
and risk factors for malignant peripheral nerve sheath 5. Mehren M von, Kane JM, Agulnik M, et al. Soft tissue
tumor: A systematic review and meta-analysis. World J Surg sarcoma, version 2.2022, NCCN clinical practice guidelines
Oncol. 2020;18:257. in oncology. J Natl Compr Canc Netw. 2022;20(7):815-833.
doi: 10.1186/s12957-020-02036-x doi: 10.6004/jnccn.2022.0035
2. Sobczuk P, Teterycz P, Czarnecka AM, et al. Systemic 6. Gronchi A, Miah AB, Dei Tos AP, et al. Soft tissue and visceral
treatment for advanced and metastatic malignant peripheral sarcomas: ESMO‑EURACAN‑GENTURIS clinical practice
nerve sheath tumors-a sarcoma reference center experience. guidelines for diagnosis, treatment and follow-up☆. Ann
J Clin Med. 2020;9(10):3157. Oncol. 2021;32(11):1348-1365.
doi: 10.3390/jcm9103157 doi: 10.1016/j.annonc.2021.07.006
3. Knight SWE, Knight TE, Santiago T, Murphy AJ, 7. Kroep JR, Ouali M, Gelderblom H, et al. First-line
Abdelhafeez AH. Malignant peripheral nerve sheath chemotherapy for Malignant Peripheral Nerve Sheath
tumors-a comprehensive review of pathophysiology, Tumor (MPNST) versus other histological soft tissue
diagnosis, and multidisciplinary management. Children sarcoma subtypes and as a prognostic factor for MPNST: An
(Basel). 2022;9(1):38. EORTC Soft Tissue and Bone Sarcoma Group study. Ann
doi: 10.3390/children9010038 Oncol. 2011;22(1):207-214.
4. Farid M, Demicco EG, Garcia R, et al. Malignant peripheral doi: 10.1093/annonc/mdq338

Volume 2 Issue 4 (2024) 5 doi: 10.36922/arnm.3462